The Valley Desk

NCT02174861 · Interventional trial

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Overall registry status Completed

Phase 2

Conditions Treatment for Prevention of Chronic Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov